Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Status:
Withdrawn
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect on the frequency of tonic-clonic and
clonic seizures of clobazam as adjunctive therapy compared to placebo after 16 weeks of
treatment in paediatric patients aged ≥1 to ≤16 years with Dravet Syndrome.